Month: March 2025

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

Written by Customer Service on March 17, 2025. Posted in Public Companies.

New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramideand Longer-Term Effect on Cardiac Structure and Function SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic cardiomyopathy (HCM), at the American College of Cardiology (ACC) Annual Scientific Session & Expo taking place from March 29, 2025–March 31, 2025 in Chicago, IL. “We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said Stephen Heitner, M.D., Vice President, Head of Clinical Research. “The presentations describe the drug metabolism of aficamten,...

Signify share repurchase period update

Written by Customer Service on March 17, 2025. Posted in Public Companies.

Press Release March 17, 2025 Signify share repurchase period update Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 145,733 shares in the period March 10 to March 14, 2025. The shares were repurchased at an average price of EUR 20.51 per share and an aggregate amount of EUR 3.0 million. Signify will use these repurchased shares to cover obligations arising from Signify’s long-term incentive performance share plan and other employee share plans. The repurchases were made as part of the company’s share repurchase program, which was announced on February 4, 2025. The total number of shares repurchased under this program to date is 830,209 shares for a total consideration of EUR 17.2 million. Details on the share buyback transactions can be found here. —...

Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology

Written by Customer Service on March 17, 2025. Posted in Public Companies.

The Annual Meeting is the foremost educational and scientific event for gynecologic oncologistsStenoparib has shown clinical benefit in heavily pre-treated patients, including those with platinum-resistant and refractory ovarian cancerFindings may reflect stenoparib’s dual PARP/Wnt pathway inhibitionBoston (March 17, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor— announced the presentation of new clinical data from its ongoing Phase 2 trial with stenoparib monotherapy in advanced Ovarian Cancer at the Society of Gynecologic Oncology (SGO) 2025 Annual Meeting on Women’s Cancer, held March 14-17 in Seattle, Washington. SGO is the world’s premier organization for...

Volaris Automotive Acquires Britehouse Automotive, Expanding Its Footprint in the Automotive Software Solutions Market

Written by Customer Service on March 17, 2025. Posted in Mergers And Acquisitions.

Strategic Acquisition Strengthens Volaris Automotive’s Offerings and Market Reach TORONTO, March 17, 2025 (GLOBE NEWSWIRE) — Volaris Automotive, an acquirer of specialized software companies serving the automotive industry, today announced the acquisition of Britehouse Automotive, a prominent developer of innovative automotive software platforms. This continues Volaris Automotive’s initiative to further expand its reach in the auto sector. Founded in 1983 in South Africa, Britehouse Automotive delivers a comprehensive dealer management software (DMS) along with custom digital solutions. With over 40 years of experience, the company has expanded its reach to become the premiere choice for auto companies across South Africa, Eswatini, Botswana, Lesotho and Namibia. In 2010, Japan-based Nippon Telegraph & Telephone Corporation...

Wearable Devices Expands to Next-Gen Neural Interaction for Everyday Life After Securing Patent in the United States

Written by Customer Service on March 17, 2025. Posted in Public Companies.

The patent protects Wearable Devices’ innovative neural measurement of weight, torque, and force applied with multiple real-world use-cases for Brain-Computer Interfaces, Industry 4.0, and Extended Reality YOKNEAM ILLIT, ISRAEL, March 17, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it has received a notice of allowance for its patent application entitled “Gesture and Voice-Controlled Interface Device” by the United States Patent and Trademark Office. Certain claims of the patent protect the Company’s revolutionary gesture-controlled interface ability to be used as wearable scale measuring real-world physical properties from the wrist....

Goodfood Exercises Common Share Repayment Right in Respect of 2025 Debentures

Written by Customer Service on March 17, 2025. Posted in Public Companies.

MONTREAL and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD), a leading Canadian online meal solutions company, announced today that it intends to repay the aggregate outstanding principal amount of $6.232 million of its 5.75% convertible unsecured subordinated debentures (the “Debentures”) which are due and payable as at March 31, 2025 (the “Maturity Date”) by exercising its option to deliver common shares to the holders of the Debentures. “In order to maintain maximum flexibility, we have elected to repay the small remaining balance of these debentures in shares, rather than cash. After discussions and approval from our Board, we believe it represents not only good corporate governance to maintain a strong cash balance and balance sheet in the current macroeconomic environment,...

HSBC Bank Plc – Form 8.5 (EPT/RI) – Bakkavor Group plc

Written by Customer Service on March 17, 2025. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Name of exempt principal trader: HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Bakkavor Group plc(c) Name of the party to the offer with which exempt principal trader is connected: OFFEROR: Greencore Group plc(d) Date dealing undertaken: 14 March 2025(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A” Greencore Group plc 2. ...

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the First Quarter of 2025

Written by Customer Service on March 17, 2025. Posted in Dividend Reports And Estimates.

CHICAGO, March 17, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the first quarter of 2025. The regular quarterly dividend, which equates to an annualized rate of $1.88 per common share, is payable on April 15, 2025, to shareholders of record as of the close of business on March 31, 2025. About Chicago Atlantic Real Estate Finance, Inc.Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) is a market-leading commercial mortgage REIT utilizing significant real estate, credit and cannabis expertise to originate senior secured loans primarily to state-licensed cannabis operators in limited-license states in the United States. REFI is...

Guardian Capital Announces March 2025 Cash Distributions for Guardian Capital ETFs

Written by Customer Service on March 17, 2025. Posted in Dividend Reports And Estimates.

TORONTO, March 17, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending March 31, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on March 31, 2025 to unitholders of record on March 25, 2025. The ex-dividend date in each case is anticipated to be March 25, 2025.Guardian Capital ETFs Series ofETF Units Distribution Frequency Trading Symbol Exchange DistributionAmount (per ETF Unit)GuardBondsTM 2025 Investment Grade Bond Fund ETF Units Monthly GBFB Cboe Canada CAD$0.0306GuardBondsTM 2026 Investment Grade Bond Fund ETF Units Monthly GBFC Cboe Canada CAD$0.0286GuardBondsTM 2027 Investment Grade Bond Fund ETF Units Monthly GBFD Cboe Canada CAD$0.0305GuardBondsTM...

Flagship Communities Real Estate Investment Trust Announces March 2025 Cash Distribution

Written by Customer Service on March 17, 2025. Posted in Dividend Reports And Estimates.

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, March 17, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (the “REIT”) (TSX:MHC.U; MHC.UN) announced today a cash distribution of US$0.0517 per REIT unit for the month of March 2025, representing US$0.62 per REIT unit on an annual basis. Payment will be made on or about April 15, 2025, to unitholders of record as of the close of business on March 31, 2025. Distributions paid to Canadian unitholders (and other non-U.S. unitholders) generally will be subject to U.S. withholding tax. Unitholders should consult their own tax advisors for advice with respect to the tax consequences of receiving a distribution from the REIT in their own circumstances. About Flagship Communities Real Estate Investment Trust Flagship...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals